Dr. Adrian Farrugia talks with us about the impediments to hepatitis C treatment

September 21, 2021

LiverWELL · An Interview with Dr Adrian Farrugia on Hepatitis C impediments to treatment

We talk to Dr Adrian Farrugia from the Australian Research Centre in Sex, Health and Society, La Trobe University.

Adrian’s research focuses on opioid overdose and take-home naloxone, experiences of hepatitis C treatment, and young people’s drug consumption and drug education.

And he is currently researching the uptake and experiences of hepatitis C treatment in Australia. This qualitative project collects the stories of people affected by hepatitis C to understand the meanings of treatment and identify impediments to uptake in an era focused on elimination.

You can contact Adrian regarding his research on

+61 (3) 9479 5102 (Work)

A.Farrugia@latrobe.edu.au

Listen to the podcast

LiverWELL acknowledges the support of the Victorian Government.

We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.

ABN 48 656 812 701

We acknowledge the traditional owners of the lands where we work - the lands of the Woi-Wurrung Wurundjeri people of the Kulin Nations. We express our gratitude to them for their continued care and curation of these lands and waters. We pay our respects to Elders past and present.

LiverWELL observes and honours the Kulin Nation's intrinsic connection to land, sky and water, and the creator Bunjil. LiverWELL is committed to being led and informed by Aboriginal and Torres Strait Islanders on bridging health outcomes for communities and improving liver health.

Topics you might be interested in

Dr. Adrian Farrugia talks with us about the impediments to hepatitis C treatment

Continue reading